Effects of 2 Initial Standard Antiretroviral Combinations Therapies on Lipid Metabolism
Status:
Unknown status
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This study is an open-label, randomized, pilot comparison of the effects of either
lopinavir/ritonavir or efavirenz in combination with tenofovir plus emtricitabine on
cholesterol metabolism, mitochondrial functioning and immune response in 50 naive HIV
patients after 48 weeks.
Phase:
Phase 4
Details
Lead Sponsor:
Juan A. Arnaiz
Collaborators:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau Germans Trias i Pujol Hospital Hospital Universitari Joan XXIII de Tarragona. Hospitales Universitarios Virgen del Rocío